These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34227275)

  • 41. Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.
    Sahay S; Nombela-Franco L; Rodes-Cabau J; Jimenez-Quevedo P; Salinas P; Biagioni C; Nuñez-Gil I; Gonzalo N; de Agustín JA; Del Trigo M; Perez de Isla L; Fernández-Ortiz A; Escaned J; Macaya C
    Heart; 2017 Jan; 103(2):139-147. PubMed ID: 27587437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Left atrial appendage occlusion with the Amplatzer Cardiac Plug could improve survival and prevent thrombo-embolic and major bleeding events in atrial fibrillation patients with increased bleeding risk.
    Budts W; Laenens D; Van Calenbergh F; Vermeersch P; De Potter T; Aminian A; Benit E; Stammen F; Kefer J
    Acta Cardiol; 2016 Apr; 71(2):135-43. PubMed ID: 27090034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Left atrial appendage occlusion in atrial fibrillation for stroke prevention: A systemic review.
    Zhou X; Zhang W; Lv W; Zhou Q; Li Y; Zhang L; Lu Y; Zhang J; Xing Q; Wang H; Tang B
    Int J Cardiol; 2016 Jan; 203():55-9. PubMed ID: 26492310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antithrombotic strategies after interventional left atrial appendage closure: an update.
    Chen S; Weise FK; Chun KRJ; Schmidt B
    Expert Rev Cardiovasc Ther; 2018 Sep; 16(9):675-678. PubMed ID: 30095350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
    Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
    Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Percutaneous left atrial appendage occlusion.
    Mohammed M; Ranka S; Reddy M
    Curr Opin Cardiol; 2021 Jan; 36(1):36-43. PubMed ID: 33264172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease.
    Raghuram P; Pavithran S; Sivakumar K
    Indian Heart J; 2020; 72(5):369-375. PubMed ID: 33189196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kidney function stratified outcomes of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and high bleeding risk.
    Brockmeyer M; Wolff G; Krieger T; Lin Y; Karathanos A; Afzal S; Zeus T; Westenfeld R; Polzin A; Heinen Y; Perings S; Kelm M; Schulze V
    Acta Cardiol; 2020 Aug; 75(4):312-320. PubMed ID: 30983505
    [No Abstract]   [Full Text] [Related]  

  • 49. Combination of catheter ablation for non-valvular atrial fibrillation and left atrial appendage occlusion in a single procedure.
    Li X; Li J; Chu H; Wang L; Shi L; Wang G; Wang X
    Exp Ther Med; 2018 Sep; 16(3):2094-2100. PubMed ID: 30186445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Percutaneous left atrial appendage occlusion in patients with a cardiac implantable electronic device.
    Staal DP; Maarse M; Aarnink E; Huijboom MFM; Abeln BGS; Rensing BJMW; Swaans MJ; Van Dijk VF; Boersma LVA
    J Interv Card Electrophysiol; 2023 Dec; 66(9):1971-1978. PubMed ID: 36856972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery.
    Yao X; Gersh BJ; Holmes DR; Melduni RM; Johnsrud DO; Sangaralingham LR; Shah ND; Noseworthy PA
    JAMA; 2018 May; 319(20):2116-2126. PubMed ID: 29800182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke.
    Hoyer C; Filipov A; Neumaier-Probst E; Szabo K; Ebert A; Alonso A
    J Thromb Thrombolysis; 2018 May; 45(4):529-535. PubMed ID: 29476304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Left atrial appendage occlusion in elderly].
    Amabile N; Elhadad S; Roig C; Sebag F; Charles P; Caussin C
    Ann Cardiol Angeiol (Paris); 2018 Dec; 67(6):444-449. PubMed ID: 30376971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.
    Chun KR; Bordignon S; Urban V; Perrotta L; Dugo D; Fürnkranz A; Nowak B; Schmidt B
    Heart Rhythm; 2013 Dec; 10(12):1792-9. PubMed ID: 23973952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation.
    Reddy VY; Akehurst RL; Amorosi SL; Gavaghan MB; Hertz DS; Holmes DR
    Stroke; 2018 Jun; 49(6):1464-1470. PubMed ID: 29739915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low Dose of Direct Oral Anticoagulants after Left Atrial Appendage Occlusion.
    Cepas-Guillen PL; Flores-Umanzor E; Regueiro A; Brugaletta S; Ibañez C; Sanchis L; Sitges M; Rodés-Cabau J; Sabaté M; Freixa X
    J Cardiovasc Dev Dis; 2021 Oct; 8(11):. PubMed ID: 34821695
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
    Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Severity and Functional Outcome of Patients with Cardioembolic Stroke Occurring during Non-vitamin K Antagonist Oral Anticoagulant Treatment.
    Tomita H; Hagii J; Metoki N; Saito S; Shiroto H; Hitomi H; Kamada T; Seino S; Takahashi K; Sasaki S; Yasujima M; Okumura K
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1430-7. PubMed ID: 25843224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study.
    Liu T; Yang HL; Gu L; Hui J; Omorogieva O; Ren MX; Wang XH
    BMC Cardiovasc Disord; 2020 Jan; 20(1):22. PubMed ID: 31948390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ablation for Atrial Fibrillation Combined With Left Atrial Appendage Closure.
    Alipour A; Swaans MJ; van Dijk VF; Balt JC; Post MC; Bosschaert MAR; Rensing BJ; Reddy VY; Boersma LVA
    JACC Clin Electrophysiol; 2015 Dec; 1(6):486-495. PubMed ID: 29759402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.